VRDN
Price
$32.28
Change
+$0.17 (+0.53%)
Updated
Dec 24 closing price
Capitalization
3.08B
70 days until earnings call
Intraday BUY SELL Signals
VTYX
Price
$9.18
Change
+$0.11 (+1.21%)
Updated
Dec 24 closing price
Capitalization
655.07M
84 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

VRDN vs VTYX

Header iconVRDN vs VTYX Comparison
Open Charts VRDN vs VTYXBanner chart's image
Viridian Therapeutics
Price$32.28
Change+$0.17 (+0.53%)
Volume$403.58K
Capitalization3.08B
Ventyx Biosciences
Price$9.18
Change+$0.11 (+1.21%)
Volume$593.31K
Capitalization655.07M
VRDN vs VTYX Comparison Chart in %
VRDN
Daily Signal:
Gain/Loss:
VTYX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
VRDN vs. VTYX commentary
Dec 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VRDN is a Hold and VTYX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 25, 2025
Stock price -- (VRDN: $32.28 vs. VTYX: $9.18)
Brand notoriety: VRDN and VTYX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: VRDN: 22% vs. VTYX: 11%
Market capitalization -- VRDN: $3.08B vs. VTYX: $655.07M
VRDN [@Biotechnology] is valued at $3.08B. VTYX’s [@Biotechnology] market capitalization is $655.07M. The market cap for tickers in the [@Biotechnology] industry ranges from $117.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

VRDN’s FA Score shows that 0 FA rating(s) are green whileVTYX’s FA Score has 1 green FA rating(s).

  • VRDN’s FA Score: 0 green, 5 red.
  • VTYX’s FA Score: 1 green, 4 red.
According to our system of comparison, VTYX is a better buy in the long-term than VRDN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

VRDN’s TA Score shows that 3 TA indicator(s) are bullish while VTYX’s TA Score has 4 bullish TA indicator(s).

  • VRDN’s TA Score: 3 bullish, 5 bearish.
  • VTYX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, VTYX is a better buy in the short-term than VRDN.

Price Growth

VRDN (@Biotechnology) experienced а +0.47% price change this week, while VTYX (@Biotechnology) price change was +19.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.88%. For the same industry, the average monthly price growth was +4.46%, and the average quarterly price growth was +55.39%.

Reported Earning Dates

VRDN is expected to report earnings on Mar 05, 2026.

VTYX is expected to report earnings on Mar 19, 2026.

Industries' Descriptions

@Biotechnology (+2.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VRDN($3.08B) has a higher market cap than VTYX($655M). VTYX YTD gains are higher at: 319.178 vs. VRDN (68.388). VTYX has higher annual earnings (EBITDA): -115.4M vs. VRDN (-298.48M). VRDN has more cash in the bank: 491M vs. VTYX (193M). VTYX has less debt than VRDN: VTYX (10M) vs VRDN (21.6M). VRDN has higher revenues than VTYX: VRDN (70.8M) vs VTYX (0).
VRDNVTYXVRDN / VTYX
Capitalization3.08B655M470%
EBITDA-298.48M-115.4M259%
Gain YTD68.388319.17821%
P/E RatioN/AN/A-
Revenue70.8M0-
Total Cash491M193M254%
Total Debt21.6M10M216%
FUNDAMENTALS RATINGS
VRDN: Fundamental Ratings
VRDN
OUTLOOK RATING
1..100
76
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
PROFIT vs RISK RATING
1..100
62
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
VRDNVTYX
RSI
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
86%
Declines
ODDS (%)
Bearish Trend 8 days ago
84%
Bearish Trend 9 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
VRDN
Daily Signal:
Gain/Loss:
VTYX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VVILX28.460.09
+0.32%
Vulcan Value Partners Institutional
PGRCX46.880.09
+0.19%
BNY Mellon Worldwide Growth C
QUAYX79.970.09
+0.11%
AB Small Cap Growth Advisor
FNIAX46.43N/A
N/A
Fidelity Advisor New Insights A
GGSOX16.29N/A
N/A
Grandeur Peak Global Stalwarts Investor

VRDN and

Correlation & Price change

A.I.dvisor indicates that over the last year, VRDN has been loosely correlated with NUVL. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if VRDN jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRDN
1D Price
Change %
VRDN100%
+0.53%
NUVL - VRDN
58%
Loosely correlated
+0.89%
XNCR - VRDN
56%
Loosely correlated
-0.13%
CLDX - VRDN
54%
Loosely correlated
+0.94%
SYRE - VRDN
54%
Loosely correlated
-0.54%
RVMD - VRDN
51%
Loosely correlated
+1.15%
More

VTYX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTYX has been loosely correlated with KYMR. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if VTYX jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTYX
1D Price
Change %
VTYX100%
+1.21%
KYMR - VTYX
40%
Loosely correlated
-0.48%
REPL - VTYX
38%
Loosely correlated
+3.81%
NAMS - VTYX
38%
Loosely correlated
-0.83%
DSGN - VTYX
37%
Loosely correlated
+1.46%
VRDN - VTYX
35%
Loosely correlated
+0.53%
More